Cancer: Limitations of therapies exposed

Nature

Volumn 484, Issue 7392, 2012, Pages 44-46

  Casanovas, Oriol ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CELL SURFACE RECEPTOR; CYTOTOXIC AGENT; DOCETAXEL; SUNITINIB; VASCULOTROPIN;

BLOOD; CANCER; CELL ORGANELLE; DISEASE TREATMENT; DRUG; ENZYME ACTIVITY; GROWTH REGULATOR; IMMUNE SYSTEM; TOXICITY; TUMOR;

ADVANCED CANCER; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BRAIN TUMOR; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GLIOBLASTOMA; HUMAN; ISOTOPE LABELING; LUNG NON SMALL CELL CANCER; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM CANCER; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859476075     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/484044a     Document Type: Article

References (18)

1. Van der Veldt, A. A. M. et al. Cancer Cell 21, 82-91 (2012).
2. Conley, S. J. et al. Proc. Natl Acad. Sci. USA 109, 2784-2789 (2012).
3. Hurwitz, H. I. et al. J. Clin. Oncol. 23, 3502-3508 (2005).
4. Jain, R. K. Nature Med. 7, 987-989 (2001).
5. Jain, R. K. Science 307, 58-62 (2005).
6. Willett, C. G. et al. Nature Med. 10, 145-147 (2004).
7. Batchelor, T. T. et al. Cancer Cell 11, 83-95 (2007).
8. Kamba, T. et al. Am. J. Physiol. Heart Circ. Physiol. 290, H560-H576 (2006).
9. Sandler, A. et al. N. Engl. J. Med. 355, 2542-2550 (2006).
10. Boehm, T., Folkman, J., Browder, T. & O'Reilly, M. S. Nature 390, 404-407 (1997).
11. Bergers, G. & Hanahan, D. Nature Rev. Cancer 8, 592-603 (2008).
12. Rini, B. I. & Atkins, M. B. Lancet Oncol. 10, 992-1000 (2009).
13. Paez-Ribes, M. et al. Cancer Cell 15, 220-231 (2009).
14. Ebos, J. M. L. et al. Cancer Cell 15, 232-239 (2009).
15. Charafe-Jauffret, E. et al. Clin. Cancer Res. 16, 45-55 (2010).
16. Folkins, C. et al. Cancer Res. 67, 3560-3564 (2007).
17. Korkaya, H. et al. PLoS Biol. 7, e1000121 (2009).
18. Casazza, A. et al. EMBO Mol. Med. 4, 234-250 (2012).